ArticleKidney3602020

Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective.

Erik V Soloff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.